{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:27:52Z","timestamp":1795094872611,"version":"4.10.2"},"reference-count":99,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":4003,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1998,9,10]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold>Senile dementia is one of the most important health problems in developed countries. The main disease causing dementia is Alzheimer's disease that is characterized by the progressive deterioration of the cholinergic system, \u03b2\u2010amyloid production and deposition, and neurofibrillary tangle formation. Most of the reviewed data, along with data from experiments performed in our laboratory, suggest that there are no changes in the number of muscarinic receptors between Alzheimer and control brains, although the receptors expressed in Alzheimer's disease brains can be anomalous in their function. The muscarinic receptor\u2010G\u2010protein interaction also seems to be impaired in Alzheimer's disease compared with control brains, as well as the G\u2010protein system, with an important decrease in the function of the Gq\/11, the most important G\u2010protein stimulating phosphoinositide hydrolysis in human brain; in addition, the second messenger system is also impaired, with a decrease in the synthesis of phosphoinositides and in the number of IP<jats:sub>3<\/jats:sub>receptors. Muscarinic cholinergic receptors are also linked to \u03b2\u2010amyloid production, stimulation of the M<jats:sub>1<\/jats:sub>subtype with agonists results in the processing of the \u03b2\u2010amyloid precursor protein to non\u2010amyloidogenic products and administration of a fraction of the \u03b2\u2010amyloid (\u03b2\u2010amyloid 25\u201335) to rats, results in a decrease in the number of muscarinic receptors in brain. M<jats:sub>1<\/jats:sub>agonists also decrease the phosphorylation of tau proteins, playing again a modulatory role in the pathogenesis of Alzheimer's disease. The existence of a link between \u03b2\u2010amyloid and tau proteins also has been reported; treatment of hippocampal neurones with \u03b2\u2010amyloid, or the 25\u201335 residue fragment, resulted in an increase in tau protein phosphorylation. The particular contribution of muscarinic receptors, \u03b2\u2010amyloid and tau proteins in the pathogenesis of Alzheimer's disease remains still unclear. Probably Alzheimer's disease could be due to a progressive degeneration in the relationship between the three components covered in this review.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1998.tb00975.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:30:29Z","timestamp":1251307829000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Alzheimer's disease: relationship between muscarinic cholinergic receptors, \u03b2\u2010amyloid and tau proteins"],"prefix":"10.1111","volume":"12","author":[{"given":"J","family":"Pav\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"de Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Sanchez","family":"de la Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(86)90005-9"},{"key":"e_1_2_1_3_2","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer A.","year":"1907","journal-title":"Allg Z Psichiatr"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb02497.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01144-2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7046051"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90131-7"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1523\/JNEUROSCI.14-07-04507.1994","article-title":"Differentia] effects on spatial navigation of immunotoxin\u2010induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis","volume":"14","author":"Berger\u2010Sweenwy J","year":"1994","journal-title":"J Neurosci"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64020749.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(95)00016-X"},{"key":"e_1_2_1_11_2","first-page":"6","article-title":"Evidence for a selective decrease in type 1 phosphatidylinositol kinase activity in brains of patients with Alzheimer's disease","volume":"5","author":"Bothmer J","year":"1994","journal-title":"Dementia"},{"key":"e_1_2_1_12_2","first-page":"121","volume-title":"Progress in Brain Research","author":"Brann MR","year":"1993"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036092"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90232-5"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5194-8_1"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10075"},{"key":"e_1_2_1_17_2","first-page":"39","article-title":"Enfermedad de Alzheimer. Bases moleculares, criterios diagnosticos y normativa terap\u00e9utica","volume":"47","author":"Cacabelos R","year":"1994","journal-title":"Jana"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(93)90090-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb03517.x"},{"key":"e_1_2_1_20_2","first-page":"359P","article-title":"Hippocampal cholinergic (muscarinic, and putative nicotinic) receptors in human cognitive disorders","volume":"88","author":"Candy JM","year":"1986","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6338589"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90758-2"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.930080110"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00208-1"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(05)80008-9"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1974.00490320001001"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.psych.48.1.649"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(91)90003-Z"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(91)90117-D"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290305"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64041888.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00311-D"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00610-H"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3810169"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910123211506"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(95)00220-D"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/359322a0"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11281-Z"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.4.2038"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.30.040190.003221"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66031113.x"},{"key":"e_1_2_1_42_2","first-page":"38","article-title":"Tau protein in normal and Alzheimer's disease brain","volume":"1","author":"Jonson GVW","year":"1996","journal-title":"Alzheimer's Disease Rev"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3040655"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90116-3"},{"key":"e_1_2_1_45_2","first-page":"2","article-title":"Cholinergic muscarinic receptor signalling by the phosphoinositide signal transduction system in Alzheimer's disease","volume":"1","author":"Jope RS.","year":"1996","journal-title":"Alzheimer's Disease Rev"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(96)00205-9"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/325733a0"},{"key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1523\/JNEUROSCI.16-03-01034.1996","article-title":"Beta\u2010amyloid\u2010related peptides inhibit potassium\u2010evoked acetylcholine release from rat hippocampal slices","volume":"16","author":"Kar S","year":"1996","journal-title":"J Neurosci"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604103141506"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)91556-3"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.13.6753"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)62410-3"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90879-X"},{"issue":"2","key":"e_1_2_1_54_2","first-page":"43","article-title":"Alzheimer disease, attention, and the cholinergic system","volume":"9","author":"Lawrence AD","year":"1995","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_1_55_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0026-895X(25)09592-6","article-title":"Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108\u201315 cells","volume":"38","author":"Lazareno S","year":"1990","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(96)00095-4"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)00075-P"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.13541"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5194-8_19"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3992249"},{"key":"e_1_2_1_61_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"\u03b2\u2010amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson MP","year":"1992","journal-title":"J Neurosci"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(93)90315-I"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1997.77.4.1081"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5194-8_2"},{"key":"e_1_2_1_65_2","first-page":"330","article-title":"Muscarinic receptor subtype\u2010specific coupling to second messengers in neuronal systems","volume":"98","author":"McKinney M.","year":"1993","journal-title":"Prog Brain Res"},{"key":"e_1_2_1_66_2","first-page":"2312","article-title":"AMPA\u2010induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function","volume":"14","author":"Muir JL","year":"1994","journal-title":"J Neurosci"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245253"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199211000-00015"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411529"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb34416.x"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)91134-9"},{"key":"e_1_2_1_72_2","first-page":"71","article-title":"Muscarinic receptors in Alzheimer's disease","volume":"18","author":"Pavfa J","year":"1996","journal-title":"Meth Find Exp Clin Pharmacol"},{"key":"e_1_2_1_73_2","first-page":"57","article-title":"Alois Alzheimer","volume":"47","author":"Perez JM.","year":"1994","journal-title":"Jano"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91780-9"},{"key":"e_1_2_1_75_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-3565(25)24267-7","article-title":"Effect of selected muscarinic cholinergic antagonists on [3H]acetylcholine release from rat hippocampal slices","volume":"244","author":"Pohorecki R","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.09.030186.002421"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91558-2"},{"key":"e_1_2_1_78_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(25)21528-2","article-title":"Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain","volume":"228","author":"Raiteri M","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90268-B"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)90562-0"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)90411-1"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199708)26:4<341::AID-SYN2>3.0.CO;2-6"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(89)90027-5"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66020877.x"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.12.030189.002335"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.17.030194.002421"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/359325a0"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.14.8337"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb02990.x"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0170202"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00603-3"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00573-9"},{"key":"e_1_2_1_93_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3940(95)12257-5","article-title":"Exposure of rat hippocampal neurons to amyloid \u03b2 peptide (25\u201335) induces the activation of phosphatidyl inositol\u20103 kinase and the activation of tau protein kinase 1 glycogen synthase kinase\u20103\u03b2","volume":"203","author":"Takashima A","year":"1996","journal-title":"Neurosci Lett"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90010-8"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00370874"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00479-O"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.5.1858"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92114-6"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2218531"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90295-9"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1998.tb00975.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1998.tb00975.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:32:52Z","timestamp":1739309572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1998.tb00975.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,10]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9,10]]}},"alternative-id":["10.1111\/j.1472-8206.1998.tb00975.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1998.tb00975.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9,10]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}